middle.news
Memphasys Advances Felix™ System Trials to Tap Brazil’s $413M IVF Market
7:28am on Monday 2nd of June, 2025 AEST
•
Biotechnology
Read Story
Memphasys Advances Felix™ System Trials to Tap Brazil’s $413M IVF Market
7:28am on Monday 2nd of June, 2025 AEST
Key Points
Clinical utility testing of Felix™ System underway at Laboratorio Androscience in Brazil
Potential licensing and investment interest from Brazilian andrology and IVF stakeholders
Brazil’s IVF market projected to reach US$413.6 million by 2032 with 11.3% CAGR
Key opinion leaders Prof. Jorge Hallak and Prof. John Aitken to promote Felix™ at major 2025 conference
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Memphasys (ASX:MEM)
OPEN ARTICLE